[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Heartbeam Inc (BEAT)

Heartbeam Inc (BEAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 39,965
  • Shares Outstanding, K 55,507
  • Annual Sales, $ 0 K
  • Annual Income, $ -21,020 K
  • EBIT $ -20 M
  • EBITDA $ -20 M
  • 60-Month Beta -0.82
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 47.24
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.56
  • Most Recent Earnings $-0.12 on 05/13/26
  • Next Earnings Date 08/12/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Information Systems

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.09
  • Number of Estimates 2
  • High Estimate $-0.08
  • Low Estimate $-0.11
  • Prior Year $-0.15
  • Growth Rate Est. (year over year) +40.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6106 +17.92%
on 06/25/26
0.9420 -23.57%
on 06/04/26
-0.1560 (-17.81%)
since 06/02/26
3-Month
0.6106 +17.92%
on 06/25/26
1.2600 -42.86%
on 04/14/26
-0.4600 (-38.98%)
since 04/02/26
52-Week
0.5400 +33.33%
on 11/21/25
4.0000 -82.00%
on 12/17/25
-0.5700 (-44.19%)
since 07/02/25

Most Recent Stories

More News
HeartBeam (NASDAQ: BEAT) Advances Modern Cardiac Care, Expanding Use of ECG Data Outside of the Hospital

Cardiac monitoring is evolving beyond the routine detection of abnormal heart rhythms toward a future where patients and physicians receive timely actionable insights that can guide clinical decisions...

BEAT : 0.7200 (-1.28%)
HeartBeam (NASDAQ: BEAT) Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study

HeartBeam (NASDAQ: BEAT) announced it has completed patient enrollment ahead of schedule in its ALIGN-ACS pilot study evaluating the HeartBeam System for heart attack detection. The study enrolled 120...

BEAT : 0.7200 (-1.28%)
HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule

Accelerated enrollment completion in ALIGN-ASS study underscores HeartBeam’s execution on its key strategic priority of heart attack detection Data analysis is underway, with...

BEAT : 0.7200 (-1.28%)
HeartBeam (NASDAQ: BEAT) Reorganizes to Accelerate Global Commercialization Strategy

HeartBeam (NASDAQ: BEAT) announced a strategic reorganization aimed at accelerating execution, expanding global market reach and improving capital efficiency as it advances commercialization of its cardiac...

RACE : 384.97 (+2.75%)
BEAT : 0.7200 (-1.28%)
HeartBeam Announces Strategic Shift to Accelerate Global Adoption of its Ambulatory ECG Signal Platform and Leadership Transition

Company will license its 3D ECG signal technology to established partners, moving beyond direct medical device sales Advancing toward heart attack detection...

BEAT : 0.7200 (-1.28%)
HeartBeam (NASDAQ: BEAT) Launches Study Focused on Testing Proprietary Patch Capable of Generating On-Demand 12-Lead ECG for Ischemia Detection

Coronary artery disease remains one of the most urgent and widespread health threats worldwide, contributing to millions of deaths each year and often progressing silently until a major cardiac event occurs....

BEAT : 0.7200 (-1.28%)
HeartBeam (NASDAQ: BEAT) Study Shows Portable ECG Device Can Help Identify Heart Attack Risk

HeartBeam (NASDAQ: BEAT) a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, announced that a peer-reviewed article in JACC: Advances demonstrated...

BEAT : 0.7200 (-1.28%)
Aggressive Insider Buying Signals Opportunity in 3 Risky Stocks

Insiders are betting big on three stocks. Board members, CEOs, and CFOs are among the buyers, signalling confidene in their fundamentals.

GRNT : 4.42 (+1.38%)
RAD : 0.6483 (-16.81%)
BEAT : 0.7200 (-1.28%)
HeartBeam Announces New Peer-Reviewed Article Demonstrating Potential to Help Identify Heart Attack Risk at Home

Publication in JACC: Advances demonstrates that an algorithm combining the HeartBeam ECG device with patient risk factors and symptoms can accurately identify heart attack risk ...

BEAT : 0.7200 (-1.28%)
HeartBeam (NASDAQ: BEAT) Aims to Close Critical Gap in Early Cardiac Detection

HeartBeam (NASDAQ: BEAT) is developing technology aimed at improving how cardiac conditions are identified and monitored, positioning its solutions at the intersection of rising clinical need and evolving...

BEAT : 0.7200 (-1.28%)

Business Summary

HeartBeam Inc. is a development stage digital healthcare company with proprietary ECG telemedicine technology. HeartBeam Inc. is based in SANTA CLARA, Calif.

See More

Key Turning Points

3rd Resistance Point 0.8205
2nd Resistance Point 0.7924
1st Resistance Point 0.7562
Last Price 0.7200
1st Support Level 0.6919
2nd Support Level 0.6638
3rd Support Level 0.6276

See More

52-Week High 4.0000
Fibonacci 61.8% 2.6783
Fibonacci 50% 2.2700
Fibonacci 38.2% 1.8617
Last Price 0.7200
52-Week Low 0.5400

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.